Journal article
Treatment of Mycobacterium abscessus Infection
Emerging infectious diseases, Vol.22(3), pp.511-514
03/01/2016
DOI: 10.3201/eid2203.150828
PMCID: PMC4766900
PMID: 26890211
Abstract
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.
Details
- Title: Subtitle
- Treatment of Mycobacterium abscessus Infection
- Creators
- Shannon A. Novosad - Oregon Health & Science UniversitySusan E. Beekmann - University of IowaPhilip M. Polgreen - University of IowaKate Mackey - Oregon Health & Science UniversityKevin L. Winthrop - University of PortlandM Abscessus Study Team
- Resource Type
- Journal article
- Publication Details
- Emerging infectious diseases, Vol.22(3), pp.511-514
- DOI
- 10.3201/eid2203.150828
- PMID
- 26890211
- PMCID
- PMC4766900
- NLM abbreviation
- Emerg Infect Dis
- ISSN
- 1080-6040
- eISSN
- 1080-6059
- Publisher
- Centers Disease Control & Prevention
- Number of pages
- 4
- Grant note
- 2T32 HL083808-06 / National Institutes of Health training grant; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA FOA CK11-1102 / Centers for Disease Control and Prevention; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA T32HL083808 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
- Language
- English
- Date published
- 03/01/2016
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984359582602771
Metrics
13 Record Views